Abstract

Fluorine-19 magnetic resonance imaging (19F MRI) with intravenously applied perfluorooctyl bromide-nanoemulsions (PFOB-NE) has proven its feasibility to visualize inflammatory processes in experimental disease models. This approach is based on the properties of monocytes/macrophages to ingest PFOB-NE particles enabling specific cell tracking in vivo. However, information on safety (cellular function and viability), mechanism of ingestion and impact of specific disease environment on PFOB-NE uptake is lacking. This information is, however, crucial for the interpretation of 19F MRI signals and a possible translation to clinical application. To address these issues, whole blood samples were collected from patients with acute ST-elevation myocardial infarction (STEMI), stable coronary artery disease (SCAD) and healthy volunteers. Samples were exposed to fluorescently-labeled PFOB-NE and particle uptake, cell viability and migration activity was evaluated by flow cytometry and MRI. We were able to show that PFOB-NE is ingested by human monocytes in a time- and subset-dependent manner via active phagocytosis. Monocyte function (migration, phagocytosis) and viability was maintained after PFOB-NE uptake. Monocytes of STEMI and SCAD patients did not differ in their maximal PFOB-NE uptake compared to healthy controls. In sum, our study provides further evidence for a safe translation of PFOB-NE for imaging purposes in humans.

Highlights

  • Non-invasive visualization of macrophages is of paramount interest in various clinical inflammatory diseases, since those cells impact on prognosis

  • No significant differences in perfluorooctyl bromide-nanoemulsions (PFOB-NE) uptake of human monocytes could be observed

  • No significant differences in PFOB-NE uptake of human monocytes could be observed between patients with ST-elevation myocardial infarction (STEMI), stable coronary artery disease (SCAD) and healthy volunteers

Read more

Summary

Introduction

Non-invasive visualization of macrophages is of paramount interest in various clinical inflammatory diseases, since those cells impact on prognosis. Has proven its feasibility to visualize inflammatory processes in a wide range of experimental disease models (e.g., myocardial infarction, stroke, graft rejection, myocarditis) [3,4,5,6,7,8]. This imaging approach is based on the properties of monocytes/macrophages to ingest PFC-NE particles with high affinity, which allows a cell type-specific tracking in vivo [3].

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call